Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-20

Clinical Trial Update: Prostate Cancer IRE Study (PRIS) [NA]

View source ↗

Summary

This clinical trial update indicates that the irreversible electroporation (IRE) study for prostate cancer (PRIS) is currently recruiting, sponsored by Karolins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Prostate Cancer | NA | Status: RECRUITING